Novel glucose-lowering drugs for non-alcoholic fatty liver disease

doi:10.4239/wjd.v12.i1.84

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8409)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

525

WORD

237

HTML

3767

Figures (1-2)

310

Tables (1-5)

323

Sum=5162

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

484

Download

1069

Sum=1553

Publishing Process of This Article

Item

Count

Browse

555

Download

1139

Sum=1694

Jan 15, 2021 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Diabetes. Jan 15, 2021; 12(1): 84-97
Published online Jan 15, 2021. doi: 10.4239/wjd.v12.i1.84

Full Size Figure Download Figure

Figure 1 Flow chart of included studies.

Citation: Fu ZD, Cai XL, Yang WJ, Zhao MM, Li R, Li YF. Novel glucose-lowering drugs for non-alcoholic fatty liver disease. World J Diabetes 2021; 12(1): 84-97
URL: https://www.wjgnet.com/1948-9358/full/v12/i1/84.htm
DOI: https://dx.doi.org/10.4239/wjd.v12.i1.84